Sign in Subscribe
Pediatrics

Virtual Care in Pediatric Lipid Clinics: Implications for COVID-19 Management

Strategic Insights

— 1 min read

Researchers in Toronto, Canada have conducted a study to evaluate the impact of virtual care on lipid profiles and patient experiences during the COVID-19 pandemic. The study, published in the Journal of Clinical Lipidology, analyzed data from 150 patients who attended both in-person and virtual appointments at a pediatric hospital from 2020 to 2024. The results showed that while virtual care visit frequency did not significantly affect non-high-density lipoprotein (non-HDL) cholesterol levels over time, lifestyle factors remained a crucial predictor of lipid outcomes.

Key Takeaways:

  • The study involved 150 patients with a mean age of 11 years and 49% female participation.
  • The trajectory of non-HDL cholesterol levels over time did not significantly differ between patients with 3 virtual care visits and those with fewer visits.
  • Suboptimal lifestyle behavior patterns were associated with higher non-HDL cholesterol levels.
  • Qualitative data from 9 patients and 10 parents revealed four themes: convenient but less effective, managing physical and psychosocial health, situational acceptance, and participant recommendations.
  • Virtual care visit frequency alone was not associated with significant changes in non-HDL cholesterol over time, but lifestyle factors remained important predictors of lipid outcomes.
  • The study concluded that recommendations for virtual care should consider factors such as families' knowledge, privacy, availability of technology, and internet accessibility.

Statistics:

  • The study analyzed data from 150 patients (mean age 11 years, SD = 3).
  • 49% of the patients were female.
  • The study found that suboptimal lifestyle behavior patterns were associated with higher non-HDL cholesterol levels.
  • 9 patients and 10 parents participated in qualitative interviews.
  • The study concluded that lifestyle factors remained important predictors of lipid outcomes (95% CI: 0.78-1.04%).

Sources:

  • Patients' and families' virtual care experiences for hypercholesterolemia management during the COVID-19 pandemic. Journal of Clinical Lipidology, 2025;19(4):969-981.
  • Journal of Clinical Lipidology, www.journals.elsevier.com/journal-of-clinical-lipidology/
  • Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA, www.elsevier.com
  • Nita Chahal, Labatt Family Heart Centre, Hospital for Sick Children, Toronto, Ontario, Canada, (Dr Chahal, Rahman, Nobile and Dr McCrindle)
  • Additional authors for this research include Arnelle Lardizabal, Janet Rush, Christian Delayun, Rayan Rahman, Rita Nobile and Brian W. McCrindle.

Read more